Sign in to follow
Search Results

0 results for ''Reed Smith''

You can use to get even better search results
February 20, 2024 | The American Lawyer

Deals Are Back. But Don't Get Too Excited

Firms with large transactional practices may see the recent rush of deals as the sign they've been waiting for. The Global Lawyer suggests they may want to curb their enthusiasm.
8 minute read
Appellate Division, First Department: February 20, 2024
Publication Date: 2024-02-20
Practice Area: Civil Appeals | Criminal Appeals
Industry:
Court: Appellate Division, First Department, Appeals & Motions
Judge: Unsigned
Attorneys:
For plaintiff:
For defendant:
Case number: DOCKET

Appeals & Motions List released on:February 15, 2024

February 19, 2024 | International Edition

Reed Smith Adds Fourth McDermott Private Equity Lawyer in Last Nine Months

The McDermott partner was previously the global head of private equity at Hogan Lovells.
2 minute read
Jaroslawicz v. M&T Bank Corp.
Publication Date: 2024-02-19
Practice Area: Securities Litigation
Industry: Financial Services and Banking | Investments and Investment Advisory
Court: U.S. District Court of Delaware
Judge: District Judge Wallach
Attorneys:
For plaintiff: Francis J. Murphy, Jr., Jonathan L. Parshall, Murphy, Spadaro & Landon, Wilmington, DE; Steven M. Coren, Benjamin M. Mather, Matthew R. Williams, Kauffman, Coren & Ress, P.C, Philadelphia, PA for plaintiffs.
For defendant: Brian M. Rostocki, Anne M. Steadman, Justin M. Forcier, Reed Smith LLP, Wilmington, DE; Jonathan K. Youngwood, Janet A. Gochman, Tyler A. Anger, Katherine A. Hardiman, Simpson, Thacher & Bartlett, New York, NY; Kevin R. Shannon, Daniel Rusk, Potter Anderson & Corroon LLP, Wilmington, DE; Tracy Richelle High, Scott A. Foltz, Sullivan & Cromwell LLP, New York, NY for defendants.
Case number: 15-00897-EJW

Although plaintiffs' experts' report in support of their damages theory for class certification used sufficiently reliable methodologies under the Daubert standard, the evidence was wholly speculative to demonstrate economic loss or proximate causation, such that plaintiffs could not meet the commonality or predominance standards.

February 18, 2024 | Law.com

Deals Are Back. But Don't Get Too Excited

Kirkland & Ellis, Latham & Watkins, Skadden, Arps, Slate, Meagher & Flom and other law firms with large transactional practices may see the recent rush of deals as the sign they've been waiting for. The Global Lawyer suggests they may want to curb their enthusiasm.
9 minute read
Law Journal Press | Digital Book Wrongful Use of Civil Proceedings and Related Torts in Pennsylvania, Second Edition Authors: George Bochetto, David P. Heim, John A. O’Connell, Robert S. Tintner View this Book

View more book results for the query "'Reed Smith'"

February 17, 2024 | Legaltech News

Don't 'Feign Ignorance' When Regulatory Agencies Come For Your Off-Channel Communication

Constantly updated your preservation policies might be a buzzkill, but in light of the recent FTC-DOJ guidance on collaboration app data, regulatory agencies are issuing some serious warnings.
6 minute read
February 16, 2024 | The Legal Intelligencer

Proposed Rule 16.1: A Fix for MDL Problems?

The proposal of Rule 16.1 poses the question of whether there are serious problems afflicting MDL procedures. And if so, is proposed Rule 16.1 the solution?
8 minute read
February 16, 2024 | Litigation Daily

Litigator of the Week Runners-Up and Shout Outs

Runners-up honors this week go to litigators at Cleary, Latham, MoFo, Simpson Thacher and Skadden.
7 minute read
February 13, 2024 | Texas Lawyer

$22M Dallas Verdict Awarded

The law firms Reed Smith and West & Associates got a jury verdict of over $22 million for a former president of a large Dallas real estate company, and defeated counterclaims of $36 million.
4 minute read
February 09, 2024 | New Jersey Law Journal

Judge Rejects Class Action Claim Filed Against Novo Nordisk, Eli Lilly and Sanofi-Aventis

"Plaintiffs have not sufficiently shown they failed to receive the benefit of the bargain as they have not alleged that they had 'a reasonable belief about the product induced by a misrepresentation'—and in fact they have asserted the opposite, that their ascertainable loss theory is not based on misrepresentation—or that they were misled into buying insulin that was worth less than was promised," Judge Brian R. Martinotti said.
7 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources